The Cell Expansion Market research report is a comprehensive and vital document encompassing business strategies, qualitative and quantitative analysis, and emerging trends of the global Cell Expansion market. The report offers in-depth research and assessment of the key elements of the global Cell Expansion market. The research analysts have formulated this report through thorough primary and secondary research with a detailed analysis of the drivers, restraints, challenges, trends, and opportunities to provide a panoramic view of the Cell Expansion market.

Furthermore, the latest document is furnished with the current market scenario impacted by the COVID-19 pandemic. It gradually unfolds the pandemic’s adverse economic effects on this business sector. The lethal viral outbreak has cost countless lives worldwide, alongside causing major disruptions to the global economy and this particular industry. The report highlights the leading competitors in this sector, the present financial standing of the market, the global supply chains, sales & distribution channels, and the profound impact of the COVID-19 restrictions on this market. The study further discovers numerous business-centric strategies implemented by the key players to gain robust traction globally.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/952

Competitive Landscape:

Key market players operating in the global Cell Expansion market and studied in the report include Danaher Corporation, Thermo Fisher Scientific, Inc., Corning Incorporated, Lonza, Merck KGAA, Terumo Corporation, Stemcell Technologies, Inc., Cellexus, Becton, Dickinson and Company, and Himedia Laboratories.

Market Segmentation:-

Emergen Research has segmented global cell expansion market based on product, cell type, application, end-user, and region:

Product Outlook (Revenue, USD Million; 2017–2027)

Consumables

Reagents

Media

Sera

Disposables

Instruments

Cell Expansion Supporting Equipment

Flow Cytometers

Centrifuges

Cell Counters

Other Supporting Equipment

Bioreactors

Microcarrier Bioreactors

Microcarrier-based anchorage-dependent bioreactors

Suspension-based anchorage-independent bioreactors

Perfusion/Hollow Fiber Bioreactors

Automated Cell Expansion Systems

Cell Type Outlook (Revenue, USD Million; 2017–2027)

Mammalian

Human

Stem Cells

Adult Stem Cells

Induced Pluripotent Stem Cells

Embryonic Stem Cells

Differentiated Cells

Animal

Microbial

Application Outlook (Revenue, USD Million; 2017–2027)

Regenerative Medicine and Stem Cell Research

Cancer and Cell-based Research

Other (clinical studies, toxicology studies)

End-User Outlook (Revenue, USD Million; 2017–2027)

Research Institutes

Biotechnology and Biopharmaceutical Companies

Cell Banks

Other End Users (hospitals and diagnostic laboratories)

Request a discount on the report @ https://www.emergenresearch.com/request-discount/952

Some Key Highlights from the Report

In April 2020, Danaher completed the acquisition of General Electric’s life science division. The acquisition cost the company USD 21.4 Billion and is a unit that employs 850 people in Massachusetts. The division will be named Cytiva.

Consumable segment accounted for a larger revenue share of product segment in cell expansion market in 2019. Availability of various reagents and media for treatment of specific types of cell is driving the demand of the segment.

Human stem cells are witnessing increased demand owing to growth in research and popularity of regenerative medicine. Application of automated systems in the production of clinical-grade stem cells is driving the growth of the segment.

Regenerative medicine & stem cell research segment accounted for largest revenue share in application segment. Increased funding for research in stem cells and growing popularity of regenerative medicine are contributing to growth of the segment.

The market in North America accounted for largest revenue share in cell expansion market in 2019. The research companies in the region a